GlassScriptPhysician profile
Salem Badr
NPI 1396189205
$24,101.97
in general payments reported to CMS, 2019-2025
20 companies · $1,233 in 2025
The $1,233 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,501 · 2020: $123 · 2021: $19K · 2022: $1,214 · 2023: $1,064 · 2024: $176 · 2025: $1,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,472.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18,066.08 | 2021-2025 | Corevalve Evolut R, Onyx Frontier |
| Edwards Lifesciences Corporation | $1,926.10 | 2021-2025 | Sapien 3 Ultra Resilia, Pascal |
| Medtronic Vascular, INC. | $1,071.35 | 2019 | |
| Boston Scientific Corporation | $934.44 | 2020-2025 | Watchman Access System, Avvigo Guidance System, Watchman |
| Abbott Laboratories | $595.40 | 2019-2025 | Mitraclip, Emboshield Nav6 |
| Abiomed | $282.28 | 2022-2023 | Impella |
| Teleflex LLC | $153.43 | 2025 | Guideliner |
| Penumbra, INC. | $142.58 | 2025 | Indigo System |
| W. L. Gore & Associates, INC. | $138.95 | 2022 | |
| Heartflow, INC. | $136.02 | 2019 | |
| Philips North America LLC | $134.29 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $107.99 | 2019 | |
| Biotronik INC. | $102.25 | 2025 | |
| Cardinal Health 200 LLC | $91.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $79.92 | 2023-2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $60.59 | 2023-2024 | Barostim Neo System |
| Amgen INC. | $31.65 | 2025 | Repatha |
| Pfizer INC. | $20.95 | 2023 | |
| Janssen Pharmaceuticals, INC | $13.38 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.53 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salem Badr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.